C. Bélizna

Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)

N. Costedoat‐Chalumeau, Lionel Galicier, O. Aumaître et al. · Annals of the Rheumatic Diseases · 2012 · 199 citations

Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: The CARMEN study

Marie‐Antoinette Sevestre, C. Bélizna, C. Durant et al. · Journal des Maladies Vasculaires · 2014 · 50 citations

Pulmonary Embolism, Thrombosis, Venous Thrombosis +14

Antiphospholipid antibodies induce vascular functional changes in mice: a mechanism of vascular lesions in antiphospholipid syndrome?

C. Bélizna, Aurélia Lartigue, Julie Favre et al. · Lupus · 2008 · 26 citations

Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

Grégoire Martin de Frémont, N. Costedoat‐Chalumeau, Estibaliz Lazaro et al. · The Lancet Rheumatology · 2023 · 26 citations

Pregnancy Outcomes, Gynecology, Gr2 Study +5

Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome

G. Urbanski, Antoine Caillon, Caroline Poli et al. · PLoS ONE · 2018 · 20 citations · Full text